About Indamed Pharmaceuticals
Indamed Pharmaceuticals is a Healthcare company. Pharmaceutical manufacturing and formulation development in India. Its Indian entity Indamed Pharmaceuticals Private Limited reported revenue of ₹4.07 Cr. Indamed Pharmaceuticals offers products and services including Tablets and Syrup and Suspensions. Its focus areas include Medical Products, Third Party Distribution, Product Supply Services and Pharmaceuticals.
Company details
Indamed Pharmaceuticals was established in 1983 and is regarded as a leading entity in the pharmaceutical sector. Innovative formulations are dedicated by the company to the discovery, development, and commercialization of medicines aimed at enhancing outcomes for patients with life-threatening diseases. High-quality and affordable products, including tablets, syrups, and suspensions, are manufactured and supplied. Third-party products are also provided, reflecting a commitment to improving human life through reliable healthcare solutions. Overseas affiliates are supported with customized product offerings.
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website indamedpharma.com
- Social Facebook
- Legal Name Indamed Pharmaceuticals Pvt. Ltd
- Date of Incorporation 18 Dec, 1985
- Jurisdiction Gujarat, India
- Indian entity revenue₹4.07 Cr
FY 2025 · +32% YoY
- Indian entity net loss-₹92.3 Lakh
FY 2025 · -23% margin
- Indian entity EBITDA₹36.3 Lakh
FY 2025 · 9% margin
Associated legal entities of Indamed Pharmaceuticals
Indamed Pharmaceuticals operates through Indamed Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Indamed Pharmaceuticals Private Limited CIN U24232GJ1985PTC008335 | Active | 18 Dec 1985 | ₹4.1 Cr | 2 | View details |
Products & Services of Indamed Pharmaceuticals
Indamed Pharmaceuticals offers a comprehensive portfolio of products and services, including Tablets and Syrup and Suspensions.
Tablets are manufactured for treating various health conditions as part of pharmaceutical formulations.
Syrup and suspensions are provided as liquid formulations intended for patient care in life-threatening diseases.
Board of directors of Indamed Pharmaceuticals Private Limited (Indamed Pharmaceuticals)
Indamed Pharmaceuticals Private Limited is the primary company behind Indamed Pharmaceuticals. The board of Indamed Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Mohitkumar Rajendrakumar Patel, appointed in 2018. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Mohitkumar Rajendrakumar Patel DIN 08286887 | Director | 01 Dec 2018 | 7 yrs 11 mo | Indamed Pharmaceuticals Private Limited |
| Darshankumar Narendrabhai Sukhadeeya DIN 08286963 | Director | 01 Dec 2018 | 7 yrs 11 mo | Indamed Pharmaceuticals Private Limited |
Financials of Indamed Pharmaceuticals
Figures of Indamed Pharmaceuticals Private Limited, the primary company behind Indamed Pharmaceuticals, for FY 2025. Revenue was ₹4.07 Cr (+32% year on year). Net loss was -₹92.3 Lakh (-23% margin). EBITDA was ₹36.3 Lakh (9% margin). Revenue has grown at a compounded annual rate of -11% over three years and +14% over five years.
- ₹4.07 CrRevenue · FY 2025 · +32% YoY
- -₹92.3 LakhNet loss · -23% margin
- ₹36.3 LakhEBITDA · 9% margin
- ₹9.3 LakhPaid-up capital
- -11%Revenue CAGR, 3 years
- +14%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Indamed Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Indamed Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Indamed Pharmaceuticals
The primary company behind Indamed Pharmaceuticals, Indamed Pharmaceuticals Private Limited, reported revenue of ₹4.07 Cr for FY 2025, up 32% year on year.
Indamed Pharmaceuticals was established in 1983 and is regarded as a leading entity in the pharmaceutical sector. Innovative formulations are dedicated by the company to the discovery, development, and commercialization of medicines aimed at enhancing outcomes for patients with life-threatening diseases. High-quality and affordable products, including tablets, syrups, and suspensions, are manufactured and supplied. Third-party products are also provided, reflecting a commitment to improving human life through reliable healthcare solutions. Overseas affiliates are supported with customized product offerings.
Indamed Pharmaceuticals offers Tablets and Syrup and Suspensions.
Indamed Pharmaceuticals operates through Indamed Pharmaceuticals Private Limited.
The legal entities of Indamed Pharmaceuticals currently have 2 directors, including Mohitkumar Rajendrakumar Patel, Darshankumar Narendrabhai Sukhadeeya.